VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,504,000 | -51.3% | 85,509 | -55.6% | 0.24% | -39.4% |
| Q3 2019 | $5,141,000 | -51.8% | 192,465 | -59.5% | 0.40% | -33.6% |
| Q1 2019 | $10,663,000 | -25.3% | 475,595 | -38.3% | 0.60% | -30.9% |
| Q3 2018 | $14,267,000 | +3644.6% | 770,355 | +4405.8% | 0.87% | +5041.2% |
| Q2 2018 | $381,000 | -74.3% | 17,097 | -74.7% | 0.02% | -78.8% |
| Q1 2018 | $1,484,000 | -26.5% | 67,507 | -22.3% | 0.08% | -25.2% |
| Q4 2017 | $2,020,000 | -96.8% | 86,917 | -96.8% | 0.11% | -96.6% |
| Q3 2017 | $63,277,000 | +184.0% | 2,755,966 | +173.1% | 3.13% | +1.5% |
| Q2 2017 | $22,282,000 | -7.8% | 1,009,143 | -4.8% | 3.09% | +23.8% |
| Q1 2017 | $24,176,000 | +85.4% | 1,059,873 | +70.0% | 2.50% | +79.8% |
| Q4 2016 | $13,040,000 | +497.3% | 623,312 | +654.7% | 1.39% | +270.1% |
| Q3 2016 | $2,183,000 | – | 82,593 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |